Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Burosumab and 1-25 (OH) Vitamin D on Human Osteoblasts — Stella

Home/Craniosynostoses/

View on ClinicalTrials.gov

Recruiting

Back to Craniosynostoses trials

Trial locations(1 site)

France

Centre de référence des craniosténoses et malformations cranio-faciales Service de neurochirurgie Pédiatrique, Bron

Key details

Sponsor

Hospices Civils de Lyon

Enrollment target

~20 participants

Started

September 2020

Primary completion

April 2029

Age range

4 Months – 18 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.